Literature DB >> 25879368

Platelet-derived growth factor type BB and collagen matrix for soft tissue reconstruction after muco-epidermoid carcinoma removal: a possible therapeutic option.

Marco Cicciù1, Alan Scott Herford, Vecchio Giada Maria, Ennio Bramanti.   

Abstract

Muco-epidermoid carcinoma (MEC) is a rare malignant tumor occurring in major and minor salivary glands. The described case shows a patient undergoing tumor resection without neck dissection. A quick diagnosis performed through clinical investigation and incisional biopsy revealed the nature of the tumor. A porcine collagen matrix was applied after the surgery in order to improve soft tissue healing. The matrix was saturated with platelet-derived growth factor type BB in order to favorite healing process and then fixed on the palate with a dental support device. Follow-up visit performed at first, second, and third weeks highlighted a quick healing of oral mucosa. Here reported is a case of a 34-year-old man who developed a muco-epidermoid oral carcinoma localized in the left upper jaw palatal side. The clinical, radiographic, and histopathologic findings, plus differential diagnoses of the case and reconstructive treatment options are also presented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25879368     DOI: 10.4103/0973-1482.136033

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Valentina Pileczki; Bobe Petrushev; Olga Soritau; Radu Septimiu Campian; Ioana Berindan-Neagoe
Journal:  Mol Cell Biochem       Date:  2016-07-02       Impact factor: 3.396

2.  Growth Factors in Oral Tissue Engineering: New Perspectives and Current Therapeutic Options.

Authors:  Luca Fiorillo; Gabriele Cervino; Pablo Galindo-Moreno; Alan Scott Herford; Gianrico Spagnuolo; Marco Cicciù
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.